Toggle main navigation
News
Insights
Meetings
Multimedia
ASCO AI in Oncology
Search
Close
AI in Oncology
Bladder Cancer
Breast Cancer
Cardio-oncology
CNS Cancers
Colorectal Cancer
Cost of Care
Infectious Diseases
Gastrointestinal Cancer
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Gynecologic Cancers
Head and Neck Cancer
Health-Care Policy
Hepatobiliary Cancer
Immunotherapy
Kidney Cancer
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Neuroendocrine Tumors
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Survivorship
Thyroid Cancer
Solid Tumors
Hematologic Malignancies
Issues in Oncology
Skin Cancer
Advertisement
The ASCO Post
Skin Cancer
Skin Cancer
Metastatic Uveal Melanoma: Darovasertib/Crizotinib Evaluated as First-Line Targeted Therapy
November 12
2 min read
In the phase I/II OptimUM-01 trial, the doublet demonstrated antitumor activity and a manageable safety profile in patients with previously untreated metastatic uveal melanoma.
Lymphoma
Relapsed or Refractory CTCL: Denileukin Diftitox May Improve HRQoL
November 11
3 min read
Skin Cancer
TIL Therapy Plus Pembrolizumab for Advanced Melanoma
October 28
3 min read
Skin Cancer
Expert Histopathology and Molecular Testing Improve Diagnosis of Ambiguous Cutaneous Melanocytic Tumors
October 28
3 min read
Skin Cancer
High-Risk Melanoma: Personalized mRNA Vaccine Plus Immunotherapy May Benefit Outcomes After Surgery
October 26
3 min read
Skin Cancer
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
October 22
3 min read
Breast Cancer
Two Studies Show Breast Cancer Survival and Mortality Gaps Are Widening Between Rural and Urban Areas
October 15
4 min read
Latest in Skin Cancer
Load More
Advertisement